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Abstract
Synaptic levels of the monoamine neurotransmitters dopamine, serotonin, and norepinephrine are modulated by their
respective plasma membrane transporters, albeit with a few exceptions. Monoamine transporters remove monoamines
from the synaptic cleft and thus influence the degree and duration of signaling. Abnormal concentrations of these neuronal
transmitters are implicated in a number of neurological and psychiatric disorders, including addiction, depression, and
attention deficit/hyperactivity disorder. This work concentrates on the norepinephrine transporter (NET), using a battery of
in vivo magnetic resonance imaging techniques and histological correlates to probe the effects of genetic deletion of the
norepinephrine transporter on brain metabolism, anatomy and functional connectivity. MRS recorded in the striatum of NET
knockout mice indicated a lower concentration of NAA that correlates with histological observations of subtle
dysmorphisms in the striatum and internal capsule. As with DAT and SERT knockout mice, we detected minimal structural
alterations in NET knockout mice by tensor-based morphometric analysis. In contrast, longitudinal imaging after stereotaxic
prefrontal cortical injection of manganese, an established neuronal circuitry tracer, revealed that the reward circuit in the
NET knockout mouse is biased toward anterior portions of the brain. This is similar to previous results observed for the
dopamine transporter (DAT) knockout mouse, but dissimilar from work with serotonin transporter (SERT) knockout mice
where Mn2+ tracings extended to more posterior structures than in wildtype animals. These observations correlate with
behavioral studies indicating that SERT knockout mice display anxiety-like phenotypes, while NET knockouts and to a lesser
extent DAT knockout mice display antidepressant-like phenotypic features. Thus, the mainly anterior activity detected with
manganese-enhanced MRI in the DAT and NET knockout mice is likely indicative of more robust connectivity in the frontal
portion of the reward circuit of the DAT and NET knockout mice compared to the SERT knockout mice.
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Introduction
Norepinephrine (NE) is a monoamine neurotransmitter impli-
cated in various behavioral and psychological functions including
learning and memory, anxiety, arousal, and mood; as well as
disorders related to these processes (e.g. addiction, depression,
attention deficit/hyperactivity disorder) [1–5]. NE innervation for
much of the brain comes from cell bodies of the locus coeruleus
(LC). These neurons have diffuse projections to many brain
regions with particularly dense innervation in limbic regions, as
well as the frontal cortex, and other monoaminergic nuclei (i.e.
serotonergic raphe nuclei and dopaminergic ventral tegmental
area).
The norepinephrine transporter (NET, SLC6A2) is responsible
for norepinephrine reuptake by the presynaptic terminal. Thus, it
removes NE from the synaptic cleft and terminates noradrenergic
neurotransmission, while re-charging presynaptic cells for future
transmission. NET is a direct target of both antidepressants and
psychostimulants [6,7]. Additionally, NET mediates dopamine
uptake in the prefrontal cortex [8–10]. Recent work in animal
models has suggested that the mechanism of drugs that treat
ADHD may include inhibition of fronto-cortical NET [11,12].
NE and NET, along with two other monoamines and their
transporters (DAT: dopamine transporter, SERT: serotonin
transporter) form a complex interacting system that influences a
broad range of affective states. Mouse knockouts for NET, DAT,
and SERT have been used to study the pharmacological,
behavioral, and anatomical consequences of disruption of these
monoamine transporters [11,13–19]. Single and multiple knock-
outs have been especially useful in investigations parsing the
molecular actions and behavioral consequences of drugs of abuse
[17,20–22]. There is now specific information about several
aspects of these rodent model systems at physiological (e.g. up/
down regulation of monoamine receptors in response to uptake
inhibition, altered concentrations of monoamine metabolites and
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related molecules) and behavioral levels (e.g. conditioned place
preference, locomotor response, drug induced response) [19,23–
27]. These genetically altered mice provide rich model systems for
assessing differential effects of cocaine on each transporter
[15,19,28–33] and other biological ramifications of the loss of
activity of one or more monoamine transporters [14,17,20,22,34–
39].
In previous work we examined consequences of DAT and
SERT KO on the functional connectivity of prefrontal cortex
neuronal circuitry, brain morphology, and metabolite levels
[40,41]. While there is some discussion about the exact definition
of ‘reward circuits’ [42–45], one generally accepted part of this
idea includes a network linking brainstem and meso-cortical-
limbic structures. In this work we concentrate on the prefrontal-
ventral striatopallidal circuit implicated in disorders involving the
reward pathway and executive functions. Localized injection of
manganese, an MR contrast agent well-established as a circuitry
tracer [46–48], into the prefrontal cortex (PFC) followed by time-
lapse whole brain MR imaging enabled quantification of the
functional connectivity of the circuitry. We have previously
reported more robust connectivity between the PFC and posterior
structures in SERT KO mice than in wildtype mice. In DAT KO
mice the same procedure revealed preservation of cortico-striatal-
thalamic connectivity, but diminished robustness in reward
circuitry distal to the thalamus. Structural and metabolic MR
analysis revealed no significant differences between these knock-
outs and wildtype controls. Hence we concluded that lifelong
transporter deficits primarily affect the degree of activity in these
circuits without major large scale anatomical or metabolic
disturbances.
Here we extend this investigation to the NET KO mouse using
the same experimental approach as for the other two monoamine
transporter knockout strains, which completes our examination of
the effects of gene knockout of the three major molecular targets of
cocaine. Magnetic resonance spectroscopy (MRS) of the striatum
was used to measure the concentration of several small molecule
metabolites present at millimolar or greater concentrations that
have been associated with disease states [49–57]. Diffusion tensor
imaging (DTI) was employed to investigate differences in brain
structure between NET KO and WT littermate mice using tensor
based morphometry to identify local structural differences between
the KO and WT mice [58,59]. We then assessed functional
connectivity of neuronal circuitry emanating from the prefrontal
cortex using manganese enhanced MRI (MEMRI) after stereo-
taxic injection of Mn2+ into the PFC in NET KO and wildtype
(WT) mice.
Co-registration of in vivo time-lapse 3D MRI scans and pair-wise
group analysis generated statistical parametric maps (SPM)
providing unbiased, voxel-wise comparisons of Mn2+ signal
throughout the entire brain. SPM analysis of Mn2+ accumulation
distal to the injection site, as a function of time, enabled
identification of functional connectivity in multi-synaptic circuits
that emanate from the PFC injection site.
This study reports the effects of life-long deletion of NET on
metabolite levels, brain structure and neuronal connectivity in the
meso-cortical-limbic reward circuitry. These findings are dis-
cussed in the context of similar work in previous studies using
SERT and DAT KO mice, providing a unique framework to
consider the roles of these neurotransmitters in brain function
and dysfunction.
Results
Reduced NAA concentration in NET KO mice is associated
with histological aberrations in the striatal-global pallidus
interface
We used magnetic resonance spectroscopy (MRS) to
measure metabolite concentrations in the striatum. Concen-
trations of metabolites were determined relative to creatine
plus phosphocreatine, which is assumed not to vary among
mice or between animals of these two genotypes [60–62].
Relative concentrations for each metabolite are shown in
Figure 1. Student’s t-test indicated that of all the metabolite
levels only N-acetyl aspartate (NAA) was statistically different
in the NET KO versus WT littermate comparison (p,0.05;
Students t-Test for Independent means). NAA in the NET
KOs was 36% lower than in WT littermates. All other
comparisons had p.0.10.
Histological evaluation through the same region in which
metabolite concentrations were measured revealed distinct
differences in neuronal organization at the interface between
the striatum and globus pallidus (Figure 2, red arrows). NET KO
mice demonstrated a poorly demarcated interface between the
striatum and globus pallidus, with axonal bundles displaying
greater variation in size and shape than in wildtype littermate
control mice (Figure 2, red arrows). In addition, the lateral
boundaries between the fiber bundles of the internal capsule and
the striatum displayed reduced regularity, showing an uneven
distribution of fibers passing through the striatum and GP. We
examined sections through the GP in three mice of each genotype
perfused after conclusion of the MRI studies that were
immunohisotchemically stained with anti-choline-acetyl transfer-
ase (ChAT) to identify cholinergic neurons. Aggregates of ChAT-
positive neurons typically line the interface between GP and other
Figure 1. NAA is significantly reduced in NET KO mice. Summary
of results from MRS showing metabolite concentrations in the striatum
relative to creatine plus phosphocreatine are shown for both cohorts of
mice. N-acetyl aspartate (NAA) is significantly different (P,0.05;
Student’s t-Test for independent means; n = 11–12) between geno-
types, with NAA for NET KO mice being 36% less than the wildtype
mice.
doi:10.1371/journal.pone.0057597.g001
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brain areas. In the NET2/2 mice, cholinergic neurons
appeared to be somewhat disorganized at the periphery of the
GP and some were even found within the GP (see Figure S1).
Such differences in neuronal types and axonal bundling could
contribute to the NAA differences between wildtype and
knockout animals that we have found in spectroscopic studies
in this region.
Tensor-based morphometry reveals minimal anatomical
differences between NET KO and wildtype littermate
mice
To gauge the extent of anatomical morphometric alterations
associated with NET deletion, we used tensor based morphom-
etry (TBM) and high contrast data sets [58,63–69] (Figure 3).
Input to the TBM pipeline was provided by the isotropic diffusion
weighted (iDWI) data sets from NET KO and WT littermate
mice obtained on fixed specimens following completion of in vivo
MEMRI experiments. Total brain volumes for the NET KO and
WT mice were not significantly different: 452618 mm3 and
465615 mm3, respectively. TBM provides deformation tensor
indices that reflect the extent of expansion and contraction that
would be required to make a WT brain similar to an NET KO
brain. Since this information is provided at every voxel, it allows
inspection of areas that are bigger or smaller in the NET KO
brains. Relatively few voxels displayed deformation tensor indices
that differed between NET KO and WT mice. At a FDR
corrected p,0.005 level of significance, approximately 4% of the
voxels in NET KO mice were (nominally) significantly expanded,
with mean expansion factor of 1.25, and 2% were contracted
relative to wildtype mice, with a mean contraction factor of 0.82.
Expansion (red) and contraction (blue) of the NET KO relative to
wildtype littermates, respectively, displayed coarse left-right
symmetry (Figure 3 and Video S2). Expansions occurred in the
more exterior parts of the brain and contractions in more interior
regions. The midline olfactory bulb was marginally contracted,
while piriform and anterior olfactory cortices were expanded
beginning approximately 2 mm anterior to bregma. Beginning
1 mm posterior to bregma, the internal capsule was expanded
Figure 2. NET KO mice display a disorganized Striatal-GP interface. Representative sections from a wildtype littermate (A and C) and a NET
KO mouse that were embedded in register in the same block, sectioned and stained for thionine-Nissl (nuclei; A and B) and Solochrome (C and D).
Three animals from each genotype were included in the same block, sectioned in register and stained in the same cup to ensure consistency and
accuracy. This co-embedding, co-sectioning procedure yields the highest degree of precision correlations currently available for co-registration of
histologic sections, which is of necessity less precise than MR dataset computational alignment. Despite this caveat, a distinct difference in axonal
organization and bundling is observed in all 6 brains examined. In (A–B) Arrows indicate the striatum/globus pallidus interface. Note the size and
regularity of the axonal swirls in (A) and the lack of regularity in (B). In (C–D) the blue-stained axonal bundles in the striatum of wildtype (arrow heads)
are of uniform size and shape while in the KO (D) they are irregularly sized bundles. Also note the presence of scattered bundles in the globus pallidus
(GP, outlined with dashed lines) in KO mouse (D) that are not seen in WT littermate (C). The lateral boundary of the internal capsule (IC) is less distinct
in the KO mouse as well. While in these representative images some of these differences between WT and KO mice are accentuated by a slightly
different angle of the histologic section, such alterations in KO mice were obvious in all three specimens regardless of slight differences in the
sectioning plane.
doi:10.1371/journal.pone.0057597.g002
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through to the cerebral peduncle, while adjacent ventromedial
and ventrolateral thalami were contracted. Further posterior
(,4 mm posterior to bregma) the midline dorsal cerebellar
lobules, aqueduct and periaqueductal gray, and brainstem were
expanded while the pontine reticular nucleus was contracted.
Anterior regions of the interior cerebellum near the midline were
contracted in the NET KO compared to wildtype mice; there is
apparently compensating expansion of the cerebellum in border-
ing regions nearer the brain surface. Cortical regions are
essentially identical in volumes in mice of the two genotypes
studied.
Functional circuitry from medial forebrain to posterior
structures is altered in NET KO mice
Consistent placement of the injection. The center of each injection site
fell within a 0.6 mm radius for all 23 animals, as measured in
aligned MR images scanned at 30 min post-injection (Figure 4).
The average injection site (6 standard deviation) was: x (lateral to
the midline) +0.8560.18 mm; y (anterior-posterior with reference
to Bregma) +1.4360.32 mm; z (dorsal-ventral from the brain
surface) 21.5760.24 mm. Histological examination of the injec-
tion site revealed no bleeding or gliosis due to the injection
Figure 3. Tensor based morphometry indicates small local volume changes between NET KO mice and wildtype littermates. FDR
corrected at p,0.005 statistical parametric maps identifying local fractional volume changes necessary to transform NET KO to wildtype; red denotes
regions where NET KO is contracted relative to wildtype and blue denotes regions where NET KO is expanded relative to wildtype. Color bar to the
left indicates local fractional volume changes (e.g. 1 implies no change, 0.5 indicates 50% reduction, 2 indicates factor of 2 expansion). Arrows on the
sagittal slice indicate locations of horizontal and axial slices. The thalmus (Th) and internal capsule (IC) are indicated. Other specific anatomical regions
can be identified using Hoff et al. [109], the Allen Brain Atlas [110] (http://www.brain-map.org/welcome.do), or The Mouse Brain Library (http://www.
mbl.org/atlas/atlas.php). Scale bar = 1 mm.
doi:10.1371/journal.pone.0057597.g003
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procedure, although the co-injected oil droplet was apparent
(Figure 5). The co-injected fluorescently labeled histologic tracer,
rhodamine-dextran-amine, was clearly visible at the injection site,
confirming its precise location at the higher resolution afforded by
light microscopy.
Pair-wise grouped voxel-wise analysis of Mn2+ tracings
reveals functional connectivity differences between NET
KO and wildtype littermates. To follow the movement of
Mn2+-induced hyperintensities in the MRI data sets, we performed
image alignment and statistical parametric mapping to compare
how NET KO and WT littermates differed in the time
dependence of Mn2+ accumulation at locations distant from the
injection site. This analysis reveals the progressive evolution of
Mn2+ accumulation through multisynaptic circuitry emanating
from the PFC that is detected as Mn+2-induced signal intensities
change from one time point to the next. Three-dimensional maps
can be color coded to demonstrate evolution over time (see Videos
S1, S2, S3, S4, S5). Two-dimensional sections through the
compiled maps superimposed on a gray-scale anatomical image
showed statistically significant (FDR corrected at p,0.001)
temporal increases in Mn2+ induced hyperintensities that differ
between genotypes (Figure 6). Colored areas show progression
from one time point to the next: green, 1 hr . pre-injection; red
4 hr .1 hr; yellow, 8 hr .4 hr; and blue, 26 hr .8 hr. Videos
that show the entire 3D data sets are available as supplementary
information (See videos S3, S4, S5).
In the SPM images that compare 1 hr post-injection images
with pre-injection images, statistically significant voxels define the
injection site (Figure 6, green). Comparison of 4 hr with 1 hr
images showed minimal extension anteriorly from the injection site
in either genotype (Figure 6, red). At 4 hr increases were seen in
the cortex (S2, GI, AIP, and Pir) ipsilateral to the injection site
between 1.4 mm and 21.5 mm from bregma in wildype mice and
to some lesser extent in the KO mice (Figure 6, red). These
increases narrowed to encompass only the piriform cortex (Pir) at
22.8 mm from bregma. Hyperintensity was also seen ipsilaterally
in most of the striatum as well as portions of the bed nucleus of the
stria terminalis (BST), ventral pallidum (VP), thalamus, and the
anterior half of the substantia nigra (SNr). The wildtype mice also
exhibited hyperintensity increases in the contralateral nucleus
accumbens (NAc) and ventral striatum. The NET KO mice
displayed similar increases from 1 hr to 4 hr; although there were
smaller contributions in the contralateral NAc and striatum, but
larger contributions in the SNr.
Progressing to 8 hr from 4 hr (Figure 6, yellow), signal intensity
increased in the wildtype mice ipsilateral to the injection site in the
anterior third of the striatum, medial thalamus posterior to
22.5 mm bregma, and a small fraction of the SNr. Contralateral
to the injection site there were increases in the motor cortex near
bregma and small portions of the medial thalamus near the
midline posterior to 22 mm from bregma. Again, the NET KO
mice showed a similar pattern from 4 hr to 8 hr, but with no
increases in the cortex and some increases in the anterior SNr.
There were genotype dependent differences at the final time
point, 25 hr post injection (Figure 6, blue). In wildtype mice
hyperintensity increases ipsilateral to the injection site were
observed in the ventral portions of the striatum, the ventromedial
thalamus, the posterior third of the SNr, and the median raphe
nucleus. Contralateral to the injection site, small increases were
seen in the medial striatum and thalamic reticular nucleus (RT),
but nothing posterior to 1 mm from bregma. For the NET KO
mice at 25 hr, the intensity increases were less extensive than for
wildtype littermates, with small areas in the ipsilateral somatosen-
sory cortex at bregma, along the midline in the paraventricular
nucleus (PVA) and in the ipsilateral posterior SNr showing
increased intensity. Table 1 summarizes the Mn2+ induced
hyperintensities that originated at the injection site and progressed
to distal parts of the brain with time and enable visualization of the
slower progression of Mn2+ towards posterior structures in the
knockout animals.
Discussion
In this study we investigated how mice with lifelong genetic
deletion of the norepinephrine transporter differ from their
wildtype littermates in aspects of metabolite levels, brain
morphology and neuronal circuitry associated with reward
pathways. We employed a panel of magnetic resonance methods
with voxelwise analyses, as well as histological confirmation. This
work extends earlier examinations of serotonin and dopamine
transporter knockout mice [40,41]. Interactions between the
Figure 4. Injection site locations are similar in wildtype and
NET KOmice. Injection site locations, represented as a sphere for each
animal of the 23 mice used in the statistical analysis of prefrontal cortex
injections, confirms accurate placement for both groups (blue: wildtype
littermates, red: NET KO). Injection site locations have been overlaid
onto axial, transverse and sagittal semi-transparent rendered images of
the MRI template (Scale bar = 1 mm).
doi:10.1371/journal.pone.0057597.g004
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dopaminergic, serotonergic and noradrenergic systems are well
known [14,20,22,38]. Comparison of differences detected by
MEMRI in the reward circuitry of mouse strains with deletion of
each of the three monoamine transporters emphasizes the
synergistic complexity of these overlapping integrated systems.
We used MRS to measure metabolite levels averaged over an
8 ml volume centered in the striatum. Only N-acetyl aspartate
levels differed between the NET KO and wildtype mice. Striatal
NAA was significantly, 36%, lower in NET KO than WT
littermates. Alterations in fiber bundles at the striatal interface with
the global pallidus are seen by histologic analysis, which may
account for this decreased NAA signal as NAA is found
predominantly in axons and nerve processes [70]. While NAA’s
cellular function and consequences of any change in concentra-
tions remain largely un-elucidated [71], it is abundant, broadly
distributed, displays a range of concentrations between different
neuronal types [72] and serves as a surrogate marker for neuronal
loss and/or neuronal viability [73]. Reduced brain NAA is
reported in a wide range of neurological disorders, including
Alzheimer’s disease, post-traumatic stress disorder, mesial tempo-
ral lobe epilepsy, and schizophrenia [51,74–76]. Thus, reduced
NAA in the NET KO is consistent with reduced neuronal viability
induced by lifelong elevated levels of norepinephrine and/or
developmental consequences of disruption of NET [77–79]. In
previous work, we observed that NAA levels in SERT KO and
DAT KO mice are not significantly different from those of
wildtype littermates [40,41]. These results highlight the different
ramifications of deletion of the different monoamine transporters.
There were no morphological alterations in the major structures
involved in the reward pathways (i.e. PFC, CP, NAC, VP, AMG,
VTA), although minor expansions and contractions throughout
the brain were detected between wildtype littermates and NET
KO mice. Similarly, in our other studies with SERT and DAT
KO mice, TBM did not reveal differences between the knockout
mice and wildtype littermates. Thus, structural changes at the
resolution employed here do not explain differences in behavioral
phenotype: compared to wildtype NET KO mice show enhanced
behavioral responses to cocaine [80,81], profound hypoalgesia
[17], reduced MPTP toxicity [82], and less immobility in forced
swim test and tail suspension test [22]. Moreover, functional
circuitry differences identified via MEMRI are not necessarily
reflected in morphology differences identified by TBM at the
resolution employed here.
MEMRI employs the unique properties of Mn2+ to analyze
functional connectivity and patterns of neuronal activity in vivo
[48,83–85]. Mn2+ preferentially enters active neurons, is trans-
ported along microtubules and transmitted across active synapses
[85,86]. Hyperintensity in MEMRI is a consequence of changes in
local Mn2+ concentrations determined by at least 4 contributing
factors: neuronal uptake at the injection site, packaging and
anterograde axonal transport, synaptic release and re-uptake, and
intracellular accumulation, likely in endoplasmic reticulum
[46,87,88]. NET absence is unlikely to affect Mn2+ uptake. The
effective delineation of circuitry in the NET KO group confirms
satisfactory uptake of Mn2+. Furthermore, by comparing time
points within each group, we ensure that any putative differences
in uptake between genotypes would not contribute to our
conclusions.
In the present work, stereotaxic injection of nanoliter amounts
of Mn2+ into the mouse prefrontal cortex (PFC) in NET KO mice
and their WT littermates revealed differences in the pattern of
functional connectivity from the PFC to distal brain regions as
deduced from time dependent manganese induced MRI hyper-
intensities far from the injection site. The lack of any remarkable
pathologic changes around the injection site in histopathologic
examination demonstrates that stereotaxic injection of Mn2+ with
fluorescent tracers can be minimally invasive despite the small
displacement occasioned by the co-injected oil droplet. Histology
also confirmed that the injection site was positioned in the desired
Figure 5. Histology of the injection site showing precise location and minimal damage. Left panel: A representative example of one brain
section through the forebrain stained with Solochrome for both nuclei and fiber tracks and imaged at low magnification shows the injection site in
the right frontal cortex (boxed region). Although the co-injected oil droplet identifying the injection site, leaves a small displacement, there is no
bleeding, gliosis, or other indication of injury. Scale bar = 200 mm. Right panel: Fluorescent micrograph of an adjacent section of the same brain. The
injection site is detected by fluorescent signal from the co-injected rhodamine-dextran tracer (red). Note that the tracer is confined to the region of
the oil droplet and a few microns above it. Some auto-fluorescence of red blood cells within parenchymal capillaries is scattered in the background.
Anatomical features revealed by a counter-stain for cellular nuclei with DAPI (blue) confirm that the location is within the forebrain. Scale bar
= 20 mm.
doi:10.1371/journal.pone.0057597.g005
Altered Reward Circuitry in the NET Knockout Mouse
PLOS ONE | www.plosone.org 6 March 2013 | Volume 8 | Issue 3 | e57597
Figure 6. Statistical parametric maps show the progression of Mn2+ accumulation over time. Representative sections through the
statistical parametric maps show the progression of Mn2+ accumulation over time. Gray background is pre-injection MDT, while the green (1 hr .
pre-injection), red (4 hr.1 hr), yellow (8 hr.4 hr) and blue (26 hr.8 hr) overlays indicate areas with increased intensity (FDR corrected at p,0.001)
compared to the preceding time point. Representative axial (A), sagittal (B), and transverse (C) sections are displayed. Videos in Supplemental
Information show the complete image data sets in each orientation for each genotype and in 3D (S3, S4, S5). Slice locations are indicated relative to
Bregma for axial, relative to midline for sagittal, and relative to the brain surface for transverse sections are indicated to the left in each panel. Specific
anatomical regions can be identified using Hoff et al. [109], the Allen Brain Atlas [110] (http://www.brain-map.org/welcome.do), or The Mouse Brain
Library (http://www.mbl.org/atlas/atlas.php). Scale bars = 1 mm.
doi:10.1371/journal.pone.0057597.g006
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forebrain location. As in previous work, there was little histologic
evidence of tissue damage [87].
The statistical parametric maps (SPMs) shown in Figure 6 reveal
the time-course and spatial extent of the active neuronal circuitry
traced out by Mn2+ induced hyperintensities in the MR images of
wildtype and NET KO mice. Table 1 indicates which anatomic
structures display Mn2+ induced hyperintensities as a function of
time after Mn2+ injection into the PFC. MEMRI measures of
active neuronal circuitry emanating from the prefrontal cortex
follow the expected prefrontal ventrostriatal pathway that is
influenced by mesolimbic and mesocortical dopaminergic projec-
tions [43,89–91].
Similarities and differences between the NET KO reported here
and the other two monoamine transporter knockout strains, DAT
KO and SERT KO, are displayed in the simplified schematic
diagrams summarizing the SPM analyses (Figure 7). These results
reveal different time courses of Mn2+ tracing in NET, DAT and
SERT KO mice (blue tracings in Figure 7). The SERT KO
MEMRI tracing extends more posteriorly than traces from their
wildtype littermates. Both the DAT KO and NET KO tracings
are truncated compared to those in their wildtype littermates,
extending only as posterior as the SNr. The prefrontal cortical and
striatal neurons normally project to multiple brain regions,
including posterior regions in the midbrain and pons.
There is a growing body of literature indicating the subtleties,
complexities and interrelatedness of the consequences associated
with NET, DAT, and SERT deletions. NET KO can up-regulate
DAT and SERT in several brain regions [34]. SERT and DAT
can accumulate and release NE as a result of heterologous ‘‘false
transmitter’’ uptake of the transmitter [38,92,93], although
‘‘occult’’ reuptake is unlikely to account for many effects observed
in these mice (see discussion in Moriya et al., In Press [94]). There
is considerable evidence for adaptations in the other monoamine
systems when one transporter is deleted (for review see Sora et al.,
2010) [95], which is perhaps best exemplified by the unusual
rewarding effects of selective NET and SERT blockers in DAT
KO mice [81].
The differences in the MEMRI tracing in posterior brain
regions may indicate that the balance of activity between anterior
and posterior projections from the PFC is altered in these
Table 1. Comparison of anatomical structures highlighted by
Mn2+ over time in NET KO and wildtype littermate mice; and
at one day post Mn2+ injection in DAT and SERT KO mice and
their respective wildtype controls.
Anatomical feature 1hr 4hr 8hr 25hr
DAT
26hr
SERT
25hr
PFC: prefrontal cortex Bi
Cortex (S, M, AIP, Cg) Bi WTic KOc Bi
STR: Striatum Bi Bic WTi Bic WTi
Pir: Piriform cortex Bic WTi
VP: ventral pallidum Bic KOi WTi Bic
ACB: nucleus accumbens Bic Bic WTic
GP: globus pallidus Bi Bic WTic Bic KOi &
WTic
AMG: amygdala Bic WTi
Septal nuclei WTi
TH: thalamus Bic Bic WTi Bic
HY: hypothalamus LH WTic KOi
SI: substantia innominata WTi WTic
SNr: substantia nigra Bi Bi Bi Bi KOic
MG: medial geniculate nu WTi
Ml: medial lemniscus WTi
VTA: ventral tegmental
area
KOi
RN: red nucleus KOi
PRN: pontine reticular
nucleus
KOi
Manganese accumulation over time in NET KO mice compared to wildtype
littermates follows a similar general time-course as seen in the SERT and DAT
KO strains. Wildtype littermates exhibit more widespread Mn2+ induced
hyperintensities than the NET KO mice at all times post-injection in PFC. At the
24 hour time point, the pattern of manganese accumulation is significantly
restricted in the NET KO compared to wildtype mice. I subscript: ipsilateral, C
subscript: contralateral, WT: wildtype only, KO: knockout only, B: both wildtype
& knockout.
Differences are considered significant at p,0.001 (FDR corrected) level.
doi:10.1371/journal.pone.0057597.t001
Figure 7. Schematic representation shows PFC associated
circuits are somewhat more robust in WT compared to NET
KO mice. Major circuits delineated by MEMRI are shown for NET, DAT,
and SERT KO mice compared with wildtype littermates. Red (WT) and
blue (DAT KO) arrows in the schematic diagram indicate Mn2+ transport
and accumulation in the different genotypes. Detailed anatomy and
timing of Mn2+ induced image changes are shown in Table 1.
doi:10.1371/journal.pone.0057597.g007
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monoamine knockout mice. This change in active connectivity
may underlie the characteristic behavioral consequences of each of
these knockouts, such as the anxiety-like phenotype of the SERT
KO [96], as contrasted with antidepressant-like phenotype of the
NET and DAT KO mice [22,97] (see review by Haenisch and
Bonisch [93]). Thus, the mainly frontal MEMRI tracing in DAT
and NET KO mice is likely to be indicative of more robust activity
and/or connectivity in the frontal portion of the reward circuit of
the DAT and NET KO mice compared to wildtype or the SERT
KO mice. In the context of understanding the genetic basis of
mental illness, Robbins and Arnsten [98] review monoaminergic
influences on executive functions of the PFC in rodents,
nonhuman primates and humans. They note that much subtler
genetic alterations in norepinephrine and dopamine signaling may
have significant influences on susceptibility for major mental
illnesses.
Conclusions
In making comparisons across the three monoaminergic systems
(DAT, SERT, NET), two caveats must be remembered: 1) there is
significant cross-talk among the systems (substrates often modulate
more than one transporter system) and 2) the transporter knockout
mice have experienced lifelong elimination of the transporter so
that both adult and developmental effects are likely. Although this
is often a criticism of constitutive gene knockout approaches, it is
likely that many gene effects in humans have a similar basis – that
is, they are present consistently throughout development and do
not suddenly appear in adulthood.
TBM analysis indicates little structural change across the
genotypes examined. Only the NET KO genotype expresses a
metabolite pattern different from wildtype mice with decreased
NAA in the striatum, which is also reflected in the subtle
dysmorphism observed histologically. Lack of aberrant behavior
post stereotaxic injections and normal histology indicate that
MEMRI using focal injection of Mn2+ in PFC is a benign
methodology.
Longitudinal recording of Mn2+ tracings from the PFC vary in
extent and intensity across the monoamine knockouts. NET and
DAT KO mice are most similar with Mn2+ tracings from PFC
restricted to the anterior portions of the reward circuit, whereas,
the SERT KO mouse is the ‘outlier’ with extensive MEMRI
tracing as far posterior as the PAG. These animals are important
model systems in a number of affective disorders (e.g. addiction,
pain, depression, anxiety, addiction) with complex behavioral and
molecular phenotypes. MRI provides mesoscopic level informa-
tion about structure and neuronal circuitry in the DAT, SERT,
and NET KO brains that can be used to aid in testing mechanistic
interpretations of monoaminergic system dysfunctions. Detecting
similarity and differences among the monoamine transporter
knockout strains with respect to functional circuitry is a promising
methodology to compile a comprehensive phenotypic/genotypic
understanding of reward pathways, drug use and addiction, as well
as mood disorders involving the monoamine transmitters and
mesolimbic circuitry.
Materials and Methods
Ethics Statement
All protocols involving animals in this work were approved by
the Institutional Animal Care and Use Committee (IACUC) of the
California Institute of Technology.
Animals
Mice null for the norepinephrine transporter have been
described previously [80,81]. These animals have a mixed
C57BL/6J –129Sv genetic background. The effects of genetic
background have been controlled in these studies by using
wildtype littermates from heterozygote x heterozygote crossings.
While it is possible that small genomic regions around the NET
locus are more likely to derive from the 129 mouse strain due to
repeated selection of the knockout NET allele, examination of the
genes adjacent to NET (a matrix metallopeptidase, a calpain
subunit and a lysophosphatidylcholinc acyltransferase centromeric
to NET and three carboxylesterase genes telomeric) provides no
strong candidates that display significant influences on brain
structures and connectivities. We used 11 NET KO (6 males and 5
females) and 12 wildtype littermates (6 males and 6 females).
Animals were between 6–7 months of age at the time of
experiments (average age of 25 weeks) and genotypes were
confirmed by PCR according to standard procedures (for details
see Perona et al., (2008)) [22].
Stereotaxic Injections
The stereotaxic injection procedure was similar to that
employed previously [41] and in approximately the same location
in the prefrontal cortex. As Koob & Moal [99] emphasize, the
prefrontal cortex (PFC) is really a system composed of the
orbitofrontal, medial prefrontal, and prelimbic/cingulate cortices.
We chose our injection site location to minimize spill over into non
PFC structures and to be consistent with earlier work in the DAT
KO and SERT KO mice [40,41].
Briefly, 3-5 nl of 600 mM Mn2+, prepared with 0.5 mg/ml
rhodamine dextran-amine (RDA; 3k; Molecular Probes/Invitro-
gen, OR, USA), was injected unilaterally into the right prefrontal
cortex (coordinates x =20.8 mm (midline), y = 1.9 mm (bregma),
z =21.8 mm (down) [100]) over 5 minutes using a quartz
micropipette guided by computer-assisted stereotaxic injector
(myNeuroLab.com, IL, USA). Following micropipette removal,
animals were transferred to the scanner and maintained under
anesthesia with 1–1.5% isoflurane in medical grade air. Inspection
of MR images obtained 1 hour after injection enabled identifica-
tion of a hypointense region indicative of the injection site. The
coordinates of this region were identified in all animals and
translated to the bregma coordinate system through application of
the transformation required to align the coordinates of the anterior
commissure in the 1 hour MR images and the high resolution
template image used throughout the study.
Magnetic Resonance Imaging
All animals were imaged prior to administration of Mn2+ to
acquire a pre-injection image and received 0.3 ml of saline
subcutaneously before each imaging session at 0:4760:14,
4:2160:17, 8:1060:13, 24:4361:04 hours post injection; no
differences in scan time were observed between the groups. The
midpoint of each 46 minute scan was identified as the ‘‘scan time’’
and will be referred to as occurring 1, 4, 8 and 25 hours after
Mn2+ injection.
An 11.7 T 89 mm vertical bore Bruker BioSpin Avance
DRX500 scanner (Bruker BioSpin Inc., Billerica, MA) equipped
with a Micro 2.5 gradient system was used to acquire all mouse
brain images with a 35 mm linear birdcage radio frequency (RF)
coil. During imaging the animals head was secured in a Teflon
stereotaxic unit within the RF coil to minimize movement and to
aid in reproducible placement. Temperature and respiration were
continuously monitored during data acquisition with temperature
maintained at 37uC and respiration maintained at a rate of 100–
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120 per minute. Similar to previous MEMRI studies [40,41,101],
we employed a 3D RARE imaging sequence [102] with RARE
factor of 4, 4 averages, TR/TEeff = 250 ms/12 ms; matrix size of
1606128688; FOV 16 mm 612.8 mm 68.8 mm; yielding
100 mm isotropic voxels with a 46 minute scan time.
Fixation for Histology and Diffusion Tensor Imaging
Mice were sacrificed 9–10 days after the final MR imaging
session. Each mouse was anaesthetized and perfused with warm
heparinized phosphate buffered saline (PBS; 30 ml) followed by
30 ml of room temperature 4% paraformaldehyde (PFA) in PBS.
Following decapitation the head was placed in 4% PFA in PBS
overnight at 4uC. Samples intended for ex vivo MRI were kept
within the skull, had all skin and cartilaginous tissue removed and
were maintained at 4uC in 0.01% sodium azide in PBS before
further processing prior to scanning.
Diffusion-Weighted MRI
Two intact heads prepared as described above were secured in a
TeflonH holder, submerged in perfluoropolyether (FomblinH,
Solvay Solexis, Inc., Thorofare, NJ) and imaged at 4uC. Diffusion
weighted images (DWI) were acquired as previously described
[40,41] using a conventional pulsed-gradient spin echo (PGSE)
sequence (TR/TE = 300 ms/11.9 ms, 25661506120 matrix,
25.6 mm615 mm612 mm FOV, 100 mm isotropic voxel size, 1
average, d= 3 ms, D= 5.2 ms, Gd = 1125 mT/m, nominal b-
factor = 3370 s/mm2). An optimized six point icosahedral
encoding scheme [103] was used for diffusion weighted acquisi-
tions with a single un-weighted reference image for a total imaging
time of 14.5 hours.
Histology
Histological examination was performed on 6 brains, 3 NET
KO and 3 wildtype littermates. Prior to processing, each brain was
removed from the skull, post-fixed for 1–3 days and sent to
Neuroscience Associates (NSA, TN, USA) for gelatin embedding
and frozen sectioning as described [40]. Brains were embedded in
a single gelatin block and sectioned in register at 30 mm thickness.
Every 12th section was stained with a Solochrome technique,
developed for our studies with NSA, and an adjacent section
mounted in DAPI-containing anti-quench and mounted for
fluorescence microscopy of the co-injected rhodamine-dextran.
Microscopy of whole brain sections was performed using a Zeiss
V8 stereoscope equipped with an Axiocam running AxioVision
4.8, bright and dark-field illumination and three fluorescent filter
cubes for DAPI, TRITC, and FITC. High magnification
assessment of rhodamine-dextran-amine and DAPI at the
injection site were obtained on a Zeiss Axioscope Z1 with an
MRM and HRC Axiocam running AxioVision 4.6 software.
Microscopy images were prepared for publication figures using
Adobe Photoshop.
Image Alignment, Processing and Statistical Parametric
Mapping
Image alignment and statistical parametric mapping were
performed as in previous work with dopamine transporter
knockout mice [41]. Briefly, images were stripped of non-brain
material [104], corrected for B1 field inhomogeneities and each
scaled to the mode of its intensity histogram [68,105,106]. A
minimum deformation template (MDT) was produced from the
pre-injection images as described [40,107]. The pre-injection
images were then warped into this MDT as described [40] and the
post-injection images were linearly aligned (12 parameter model)
to the pre-injection images using Alignlinear, followed by
application of the polynomial warp field used to transform that
sample’s pre-injection image into the MDT. Final images were
blurred with a 0.3 mm Gaussian kernel and a paired Student’s t-
test with false discovery rate (FDR) correction was used to
determine which voxels increased in intensity when comparing
one time point to the next. Statistical significance was considered
reached at a False Discovery Rate (FDR)-corrected p,0.001.
Parametric maps of voxels with statistically significant changes in
intensity were created to display the results and to correlate
increases with underlying anatomy [106]. All processing after skull
stripping was performed using the LONI pipeline environment
[108]. Anatomy was determined with reference to Hoff et al. [109]
and the Allen Brain Atlas [110] (http://www.brain-map.org/
welcome.do).
In vivo Magnetic Resonance Spectroscopy
In vivo mouse brain magnetic resonance spectroscopy (MRS)
employed Point Resolved Spectroscopy (PRESS) [111] with a
short echo time TR/TE = 2.3 s/7.27 ms, with a spectral width of
7 KHz, 4000 data points in each free induction decay signal (FID),
and 128 averages. The sequence was preceded by a VAPOR
water suppression module [112] interleaved with outer volume
saturation. Optimized second order shimming was done with the
FastMap routine [113] in a 5 mm cube centered in the striatum.
The PRESS spectra were then recorded inside a (2 mm)3 volume
(8 ml) in the striatum at the center of the volume used for
shimming.
For each mouse brain (n = 11 NET KOs and n = 12 wildtype)
the spectrum of the relative amount of metabolites inside the
experimental PRESS volume was quantified using the QUEST
(quantitation based on quantum estimation) module [114]
available inside the Java Magnetic Resonance User Interface
(JMRUI) package [115]. Spin parameters (number of spins,
chemical shifts, J-couplings) were obtained from Govindaraju
[116]. Metabolite amounts obtained by the QUEST were
normalized to creatine plus phosphocreatine.
Tensor-based morphometry
Six icosahedrally directed diffusion weighted images were averaged
to generate a high CNR isotropic diffusion weighted image (iDWI). A
deformation field analysis implemented by Dinov, Thompson and
coworkers [117,118] was used to analyze morphological differences
between 8 NET KO images and 12 wildtype litermate brain images;
processing was implemented in the LONI Pipeline Processing
Environment. All scans were mapped into the wildtype iDWI
minimum deformation template (MDT) and the Jacobian determinant
of the displacement field (det|JTJ|, with J the deformation Jacobian) for
each scan determined. An FDR corrected independent samples t-test
assessing the difference between the absolute value of the determinants
of the displacement fields of the wildtype and NET KO identified areas
of local expansion and shrinkage [117]. Statistical significance was
considered reached at an FDR-corrected p,0.005.
Supporting Information
Figure S1 Representative examples of brain sections
stained for choline acetyl transferase (ChAT) from one
of the wildtype (NET+/+) and one of the NET knockout
(NET2/2) mice analyzed by MRI in this study. Note that
9 ChAT-stained neurons appear in the lower 1/3 of the globus
pallidis (GP) in the NET2/2 whereas only one is apparent in the
NET +/+. Scale bar = 200 mm.
(TIF)
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Video S1 Sections through statistical parametric maps
show local changes in the determinant of the deforma-
tion tensor: det|J|, where J is the deformation Jacobian.
Regions showing significant (FDR corrected p,0.005) expansion
of KO relative to wildtype (det|J|,0) are shown in blue and
contractions ((det|J|.0) in red with the color scale indicating
extent of fractional change in local volume. Gray background is
pre-injection MDT.
(MPG)
Video S2 Axial sections.
(MPG)
Video S3 Sagittal sections.
(MPG)
Video S4 Transverse sections.
(MPG)
Video S5 Three dimension rendering. Sections through the
statistical parametric maps show the progression of Mn2+
accumulation over time. Gray background is pre-injection
MDT, while the colored overlays denote areas with increased
intensity (FDR corrected p,0.001) at 1 hr (green), 4 hr (red), 8 hr
(yellow), and 24 hr (blue) compared to the preceding time point.
Videos show consecutive sections in the axial, sagittal, and
transverse directions for the NET KO and wildtype cohorts. Slice
locations are shown at the bottom right in millimeters with respect
to Bregma, midline, and the brain surface for axial, sagittal, and
transverse sections, respectively. Scale bar = 1 mm.
(MP4)
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